Publishing Details
Contact & Outreach
About This Podcast
Explore Statistics
Recent Episodes
S1E21 There are no longevity drugs today, but there will be soon - Dr. James Peyer, Cambrian Founder
Dr. James Peyer is founder and CEO of Cambrian Bio. James has spent two decades working to bring the first longevity drug to market. In this time, he’s brought over $500M into the field as a whole,…
S1E20 Aging kills EVERYONE, but only because we're not trying hard enough - Longevity Activist Nathan Cheng
Nathan Cheng is an activist who has dedicated his life and career to defeating aging and death. After going through an existential crisis and dropping out of a Physics PhD, Nathan discovered the…
S1E19 The one-man biotech is only 10 years away - a16z-backed founder Kexin Huang
Today’s guest is Kexin Huang. Kexin recently raised $13.5M from Andreessen Horowitz and Menlo Ventures in partnership with Anthropic, to build Phylo - a research lab studying agentic biology. Phylo’s…
S1E18 These 30-something Harvard Professors are making biology programmable - AbuGoot Lab
Two young Harvard professors are coming for the supplements industry. Dr. Jonathan Gootenberg and Dr. Omar Abudayyeh run a joint lab at Harvard Medical School, have co-founded 4 biotechs, and raised…
S1E17 Longevity politics with the Forbes 30U30 lobbyist changing DC - Dylan Livingston, A4LI
Today’s guest is Dylan Livingston, the 28 year old founder of the Alliance for Longevity Initiatives, known as A4LI. With A4LI, Dylan has created America’s first and only lobbying group focused on…
S1E16 Ex-BCG leader & David Sinclair’s COO on why evolution selected for aging, and how to get big pharma to invest into longevity therapies - Michael Ringel
Dr. Michael Ringel is a leader in pharma and biotech who spent over 25 years at Boston Consulting Group, where he served as managing director and senior partner, advising top pharma companies on…
S1E15 Longevity science & philosophy with the blogger leading theory at Sam Altman’s $1B+ startup - Jose, Author Nintil & Head of Theory at Retro
Jose Luis Ricón Fernández de la Puente is the author of the popular blog Nintil, and Head of Theory at Retro Biosciences. Jose is a prolific blogger, covering a wide breadth of topics across…
S1E14 Inside the AI used by Sam Altman’s $1B+ longevity startup - Rico Meinl, Head of Applied AI at Retro Bio
Retro Biosciences was seeded with $180M by OpenAI CEO Sam Altman to develop therapies to prevent and reverse age-related disease, and is widely recognized as one of the leading AI for longevity…
S1E13 Why DNA Damage is Central to Aging — Christopher Bradley, CEO of Matter Bio
Christopher is a serial entrepreneur who has dedicated himself to solving aging after his last startup Mana Health was acquired by NBC Universal. His company Matter Bio is developing therapies to…
S1E12 The moral and economic case for delaying aging - Raiany Romanni-Klein
Raiany Romanni-Klein is a Harvard and Brown-trained bioethicist focused on understanding why secular people like to narrate death and aging as good things, and quantifying the economic impacts of…
S1E11 Achieving Longevity Escape Velocity with patient avatars — Martin Borch Jensen, CSO of Gordian Biotechnology
Martin Borch Jensen is a scientist, entrepreneur and longevity advocate. He is the co-founder and CSO of Gordian Biotechnology, a company whose platform enables the simultaneous delivery and testing…
S1E10 How a Stanford & Google AI pioneer invests in longevity biotech - Karl Pfleger
Today’s guest is Karl Pfleger. After spending a decade as one of the first AI researchers at Google from 2002 to 2011, he has dedicated himself to the cause of rejuvenation biotechnology for nearly a…
S1E9 Finding genes at scale for age reversal - Shift Bio CEO Daniel Ives
Dr. Daniel Ives is the founder of Shift Bioscience. Shift has built a novel single-cell aging clock that has enabled them to run high-throughput screens to discover genes that regulate aging, with…
S1E8 Polyphron CEO Matthew Osman on his Computation-First Tissue Foundry
Polyphron is led by co-founder and CEO Matthew Osman, a twice-exited tech entrepreneur turned biotech founder. Matthew is building a computation-first tissue foundry that applies AI and lab…
S1E7 NFX GP Dr. Omri Drory on how to end involuntary death
Dr. Omri Amirav-Drory is a General Partner at NFX whose mission in life is to end involuntary death. Omri has backed companies like Mammoth Biosciences, Immunai, and Centivax, and has earned a…
S1E6 NewLimit Co-Founder Jacob Kimmel on Reversing Aging with Predictive Biology
Dr. Jacob Kimmel is the President of NewLimit, a biotechnology company developing reprogramming medicines to treat age-related disease and extend human healthspan. Dr. Kimmel co-founded the company…
S1E5 How a serial tech entrepreneur is fomenting a revolution to cure aging and death - Adam Gries
Adam Gries is a serial entrepreneur with four successful exits, and products that have reached over eighty million users. He has now set his sights on creating a longevity revolution through his…
S1E4 Reprogramming the cell from aged to healthy with siRNA - Dr. Janine & Rob (Junevity)
Dr. Janine Sengstack and Rob Cahill, founders of the startup Junevity, are on a mission to extend lifespan and healthspan by combining AI and large scale omics data with genetic medicines known as…
Thiel fellow on how longevity can fix biotech - Lada Nuzhna
Lada Nuzhna is a researcher and founder driven by two questions: how did we get here, and how do we stay. Lada dropped out of college to pursue her biology research as a Thiel fellow, and to co-found…
How a Stanford aging biologist invests in longevity - Dr. Alex Colville
Alex Colville, PhD, is a Co-founder and General Partner at Age1, one of the premier aging venture capital firms where he has invested in companies like Science, Gordian, Loyal, and General Control.…
Frequently Asked Questions
Free Radicals has published 21 episodes since November 2025, covering topics in Life Sciences, Science.
Free Radicals is currently declining with new episodes weekly. Average episode length is 1h 16m.
Sign up on Grep.FM to access contact details for Free Radicals, including email and social media links.
